Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696747 · ClinicalTrials.gov registry record
Gastroparesis Registry 2
A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- 506
- Enrollment target
NCT01696747: Completed study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT01696747 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 506 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01696747 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- 506 participants
- Enrollment target
Study Summary
To expand a registry of patients for the study of the epidemiology, etiology, and degree of morbidity associated with gastroparesis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-04-30 |
What the finished NCT01696747 record still lists
NCT01696747 is an observational study that tracks outcomes without assigning an intervention. The registered 506 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01696747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01696747 about?
NCT01696747 is a clinical study titled "Gastroparesis Registry 2". To expand a registry of patients for the study of the epidemiology, etiology, and degree of morbidity associated with gastroparesis.
What is the current status of trial NCT01696747?
This trial is currently completed. The enrollment target is 506 participants. The study started on 2012-07. Estimated completion is 2019-04-30.
Who is sponsoring clinical trial NCT01696747?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT06164717 · 507 participants · NA
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia